Introduction {#Sec1}
============

The yeast *Saccharomyces cerevisiae* is a well-known eukaryal cell factory for producing many valuable chemicals and proteins (Huang et al. [@CR13]), due to its fast growth and robustness (Hong and Nielsen [@CR10]) and being Generally Recognized As Safe (GRAS) (Shusta et al. [@CR29]). Furthermore, the ease of doing genetic manipulation, the availability of many molecular tools, datasets and databases facilitate work with *S. cerevisiae* (Cox and Mann [@CR5]; Hawkins et al. [@CR9]; Reaves and Rabinowitz [@CR25]; Snyder and Gallagher [@CR30]). Like other *Eukarya*, *S. cerevisiae* has a secretory pathway, which means that recombinant proteins can undergo folding, disulfide bond formation, glycosylation, and be transported out of the cell (Hou et al. [@CR12]). However, the secretory capacity of wild type *S. cerevisiae* is limited (Idiris et al. [@CR15]), and improving the secretory capacity through engineering of this pathway would reduce the cost of downstream processes (Nielsen [@CR20]). Over the past few years, we have successfully improved recombinant protein secretion by *S. cerevisiae* (Hou et al. [@CR11]; Huang et al. [@CR14]; Liu et al. [@CR18]; Martínez et al. [@CR19]). Liu et al. reported that different signal peptides have different effects on the secretion of recombinant proteins (Liu et al. [@CR18]). The signal peptide is recognized by the signal recognition particle on the endoplasmic reticulum (ER), and the recombinant protein is co-translationally translocated into the ER (Plath et al. [@CR23]). The nascent peptide undergoes disulfide bond formation in the ER with the assistance of the chaperone Pdi1p. Schröder and Robinson reported that overexpressing *PDI1* improves recombinant protein secretion in yeast (Robinson et al. [@CR26]; Schröder [@CR27]). High level of recombinant protein expression may, however, cause ER stress due to protein misfolding. When unfolded proteins accumulate in the ER, the so-called unfolded protein response (UPR) will be triggered to relieve ER stress (Hou et al. [@CR12]). Overexpression of the transcription factor Hac1p, which is one of the key regulators of the UPR, enhances the secretion of α-amylase (Valkonen et al. [@CR36]). Additionally, engineering the vesicle trafficking successfully increases heterologous protein secretion. Hou et al. found that overexpression of Sly1p, an SM (Sec1/Munc-18) family protein that regulates trafficking from the ER to the Golgi, enhances α-amylase secretion but not for human insulin precursor or invertase, whereas overexpression of Sec1p, which also belongs to the SM family, improves the secretion of all three proteins (Hou et al. [@CR11]). Recently, we found that engineering the anterograde trafficking between the ER to the Golgi by moderate overexpression of *SEC16* increases recombinant protein secretion (Bao et al. [@CR2]). Sec16p, an ER peripheral protein, accumulates at the ER exit sites (ERESs) and serves as a scaffold for the formation of coat protein complex II (COPII) vesicles which transport the cargo protein from the ER to the Golgi (Jensen and Schekman [@CR16]; Supek et al. [@CR32]). In *S. cerevisiae*, the native level of Sec16p is lower than that of the other COPII vesicle proteins, which may cause a limitation in the COPII vesicle formation (Feizi et al. [@CR8]). Moderate expression of *SEC16* generates more ERESs facilitating the formation of COPII vesicles. A less expanded ER combined with the result of reactive oxygen species (ROS) staining indicates a reduced level of ER stress in *SEC16* overexpression strain (Bao et al. [@CR2]). The early secretory pathway is bidirectional: anterograde trafficking mediates the transportation of cargo protein from the ER to the Golgi, and the retrograde trafficking mediated by coat protein complex I (COPI) vesicles retrieves the necessary components for continued anterograde trafficking (Pelham [@CR21]; Poon et al. [@CR24]). The process of COPI-coated vesicle formation is similar to that of COPII-coated vesicles. GDP bounded Arf1p is activated by guanine exchange factor (ArfGEF) by exchanging GDP with GTP, which triggers the formation of COPI-coated vesicles (Poon et al. [@CR24]). Following this the coatomers are recruited by the activated Arf1p-GTP followed by recruitment of the cargo proteins. The COPI-coated vesicles are formed subsequently. The mature COPI vesicles are prompted by the disassembly of coatomers, which is caused by GTP hydrolysis via the GTP activating proteins (GAPs) Gcs1p and Glo3p (Poon et al. [@CR24]).

In our previous study, we found that moderate overexpression of *SEC16* increases secretion of a range of heterologous proteins by *S. cerevisiae* (Bao et al. [@CR2]). Overexpression of *SEC16* provides more ERESs for cargo protein export. However, the enhanced flux of ER-to-Golgi transportation may bring excess lipids and ER associated proteins, such as v-SNARE proteins, to the Golgi via COPII vesicles (Szul and Sztul [@CR33]). Sequential coupling between COPII and COPI vesicles is important to coordinate and direct bi-directional vesicular trafficking between the ER and the Golgi apparatus (Aridor et al. [@CR1]), suggesting that improving the recycling of these components would further increase the trafficking flow to enhance protein secretion.

Here we used the recombinant protein α-amylase from *Aspergillus oryzae* as a reporter to evaluate the secretory capacity in yeast. We amplified the retrograde trafficking pathway by overexpressing GAPs, Gcs1p and Glo3p, in a *SEC16*-overexpression strain to further increase the secretion of heterologous proteins in yeast.

Materials and methods {#Sec2}
=====================

Strains and media {#Sec3}
-----------------

The strains and plasmids used in this study are listed in Table [1](#Tab1){ref-type="table"}. The primers used in this study are listed in Additional file [1](#MOESM1){ref-type="media"}: Table S1. Yeast strain CEN.PK530-6CK (*MATa URA3 HIS3 LEU2 TRP1 SUC2 MAL2*-*8*^*c*^ *tpi1(41*-*707)::loxP P*~*GPD*~-*SEC16*) was used as a heterologous protein secretion host. Plasmid pAlphaAmyCPOT, which contains α-amylase from *Aspergillus oryzae* with α-factor leader was transformed into CEN.PK530-6CK, named YIGS16 (Bao et al. [@CR2]). The yeast strains CEN.PK530-6CK + EG and CEN.PK530-6CK + AGL were constructed in the same way as YIGS16, that is the plasmids pAlphaTrEGCPOT and pCP-aGLA were transformed into CEN.PK530-6CK respectively, resulting CEN.PK530-6CK + EG and CEN.PK530-6CK + AGL (Bao et al. [@CR2]).Table 1Plasmids and strains used in this studyNameDescriptionReferencesPlasmids CPOTudTPI promoter and terminator from *S. cerevisiae*, *POT* marker from *Schizosaccharomyces pombe* (2 μ)Liu et al. ([@CR18]) pAlphaAmyCPOTα factor leader with α-amylase gene inserted into CPOTudLiu et al. ([@CR18]) pAlphaTrEGCPOTα factor leader with endoglucanase I gene inserted into CPOTudBao et al. ([@CR2]) pCP-aGLAα factor leader with glucan 1,4-α-glucosidase gene inserted into CPOTudHuang et al. ([@CR14])Strains CEN.PK530-6CK*MATa URA3 HIS3 LEU2 TRP1 SUC2 MAL2*-*8*^*c*^ *tpi1(41*-*707)::loxP P*~*GPD*~-*SEC16*Bao et al. ([@CR2]) YIGS16CEN.PK530-6CK with pAlphaAmyCPOTBao et al. ([@CR2]) YIGCS1YIGS16 *amdSYM P*~*TEF*~-*GCS1*This study YIGLO3YIGS16 *amdSYM P*~*TEF*~-*GLO3*This study AACK*MATa URA3 HIS3 LEU2 TRP1 SUC2 MAL2*-*8*^*c*^ *tpi1(41*-*707)::loxP* with pAlphaAmyCPOTBao et al. ([@CR2]) AACK-GCS1AACK *amdSYM P*~*TEF*~-*GCS1*This study AACK-GLO3AACK *amdSYM P*~*TEF*~-*GLO3*This study YIGLO3GCS1YIGS16 *P*~*TEF*~-*GLO3 amdSYM P*~*TEF*~-*GCS1*This study CEN.PK530-6CK + EGCEN.PK530-6CK with pAlphaTrEGCPOTThis study CEN.PK530-6CK + AGLCEN.PK530-6CK with pCP-aGLAThis study GLO3 + EGCEN.PK530-6CK *amdSYM P*~*TEF*~-*GLO3* with pAlphaTrEGCPOTThis study GLO3 + AGLCEN.PK530-6CK *amdSYM P*~*TEF*~-*GLO3* with pCP-aGLAThis study

The promoter replacement cassette "UP(GCS1)-amdSYM(GCS1)-TEF(GCS1)-DW(GCS1)" for *GCS1* was constructed by the following steps: The "UP(GCS1)" fragment is the upstream flanking region, which was amplified from the yeast genome by using primers GCS1-up-100-F and GCS1-up-100-R-amds; the "amdSYM(GCS1)" is the selection marker, which was amplified from plasmid pamdSYM by primers amdS-F and REC-amdSYM-R(gcs1); The "TEF(GCS1)" fragment is the promoter *P*~*TEF*~ which was amplified by REC-P-TEF1-F(GCS1) and gcs1-TEF1-R based on the yeast genome; The "DW(GCS1)" fragment is the downstream flanking region, which was amplified from the yeast genome by primers GCS1-F and GCS1-MID-R; then the four fragments "UP(GCS1)", "amdSYM", "TEF" and "DW(GCS1)" were jointed together by fusion PCR, resulting in the replacement cassette "UP(GCS1)-amdSYM(GCS1)-TEF(GCS1)-DW(GCS1)". Similarly, the promoter replacement cassette "UP(GLO3)-amdSYM(GLO3)-TEF(GLO3)-DW(GLO3)" was constructed by using primer pairs "GLO3-up-120-F and GLO3-up-120-R-amds", "amdS-F and REC-amdSYM-R(glo3)", "REC-P-TEF1-F(glo3) and glo3-TEF1-R" and "GLO3-F and GLO3-MID-R" for amplification of fragments "UP(GLO3)", "amdSYM(GLO3)", "TEF(GLO3)" and "DW(GLO3)" respectively, and then jointing together by fusion PCR. The replacement of the *GCS1* native promoter or the GLO3 native promoter by the TEF promoter was completed by transforming the replacement cassette "UP(GCS1)-amdSYM(GCS1)-TEF(GCS1)-DW(GCS1)" or "UP(GLO3)-amdSYM(GLO3)-TEF(GLO3)-DW(GLO3)" into the cell. Yeast strain AACK-GCS1 was constructed by transformation of the "UP(GCS1)-amdSYM(GCS1)-TEF(GCS1)-DW(GCS1)" cassette to strain AACK. The strains AACK-GLO3, YIGLO3, GLO3 + EG and GLO3 + AGL were constructed by transformation of the "UP(GLO3)-amdSYM(GLO3)-TEF(GLO3)-DW(GLO3)" cassette to strains AACK, YIGS16, CEN.PK530-6CK + EG and CEN.PK530-6CK + AGL, respectively. The transformants were selected on acetamide plate (Solis-Escalante et al. [@CR31]). The acetamide medium contained 3 g/L KH~2~PO~4~, 0.5 g/L MgSO~4~·7H~2~O, 0.6 g/L acetamide, 6.6 g/L K~2~SO~4~, 1 mL/L of a trace element solution (Verduyn et al. [@CR37]) and 1 mL/L a vitamin solution (Verduyn et al. [@CR37]). The yeast strain YIGLO3GCS1 was constructed by the following steps: The amdSYM marker was removed from YIGLO3 genome in YPD medium, and the colonies were counter-selected on a fluoroacetamide plate as described (Solis-Escalante et al. [@CR31]). Then the promoter replacement cassette "UP(GCS1)-amdSYM(GCS1)-TEF(GCS1)-DW(GCS1)" was transformed into the YIGLO3 amdSYM-removal strain, resulting in YIGLO3GCS1.

Under non-selective conditions, yeast strains were grown in YPD medium containing 10 g/L yeast extract, 20 g/L peptone and 20 g/L glucose. The yeast strains were cultured in SD-2xSCAA (Wittrup and Benig [@CR39]) medium for recombinant protein production containing 20 g/L glucose, 6.9 g/L yeast nitrogen base without amino acids, 190 mg/L arginine, 400 mg/L aspartic acid, 1260 mg/L glutamic acid, 130 mg/L glycine, 140 mg/L histidine, 290 mg/L isoleucine, 400 mg/L leucine, 440 mg/L lysine, 108 mg/L methionine, 200 mg/L phenylalanine, 220 mg/L threonine, 40 mg/L tryptophan, 52 mg/L tyrosine, 380 mg/L valine, 1 g/L BSA, 5.4 g/L Na~2~HPO4, and 8.56 g/L NaH~2~PO~4~·H~2~O (pH = 6.0 by NaOH). The cultivation time for tube fermentation was 96 h. In the bioreactor batch fermentations, SD-2xSCAA medium was used. Strains were inoculated into 600 mL of SD-2xSCAA medium in a 1-L bioreactor (DasGip, Jülich, Germany) at 30 °C. The bioreactor system was run at 600 rpm, and 36 L/h air flow, and the pH value was maintained at 6 by the addition of NaOH.

Analytical methods {#Sec4}
------------------

The cell dry weight and the concentration of glucose, ethanol and glycerol were detected as described previously (Hou et al. [@CR11]). Briefly, a high performance liquid chromatography (HPLC) (Dionex, Sunnyvale, CA, USA) was used with an Aminex HPX-87H column (Bio-Rad, Hercules, USA) at 65 °C. 5 mM H~2~SO~4~ was used as mobile phase with a flow rate of 0.6 mL/min.

Enzyme activity quantification {#Sec5}
------------------------------

The amylase enzyme activity was quantified by the assay kit (Megazyme K-CERA, Wicklow, Ireland). α-Amylase from *A. oryzae* was used as a standard. The enzyme activity of endoglucanase was measured by a cellulase assay kit (Megazyme K-CELLG3) at 50 °C for 10 min. The enzyme activity of glucan 1,4-α-glucosidase was measured by an amyloglucosidase assay kit (Megazyme R-AMGR3, Wicklow, Ireland).

Intracellular α-amylase extraction {#Sec6}
----------------------------------

Yeast cells were harvested and washed by 1× phosphate buffer solution (pH 7.4) (PBS) twice. Then the cell pellets were resuspended in 1 mL 1× PBS with 10 μL of halt protease inhibitor cocktail (Thermo Fisher, Waltham, MA, USA). Next, 500 μL cell solution was transferred into 1.0 mm silica spheres lysing matrix tube (MP Biomedicals, Santa Ana, CA, USA). The cells were lysed using fastprep-24 tissue and cell homogenizer (MP Biomedicals, Santa Ana, CA, USA) at 6.5 m/s for 2 min. The cells were kept on ice during the 5 min interval between the two runs. The supernatant was collected by centrifugation for α-amylase quantification. The cell wall associated α-amylase was considered as intracellular α-amylase.

Reactive oxygen species measurement {#Sec7}
-----------------------------------

The cells for reactive oxygen species (ROS) measurement were cultivated in tube at 30 °C and collected when OD~600~ reached 1. Then 1 OD~600~ of the cells of each samples were washed by 1× PBS twice and 50 mM sodium citrate buffer (pH 5) (SCB) once. The cell pellets were resuspended in 1 mL of SCB with 1 μL of 50 mM dihydrorhodamine 123 (Thermo Fisher, Waltham, MA, USA), and then were incubated in the dark at room temperature for 30 min. After the incubation, the cells were washed and resuspended in 1 mL of SCB. 200 μL of the cell samples were loaded into 96-well black plate for detection by fluorescence microplate reader (FLUOstar Omega, BMG LABTECH, Germany) with a 485-nm excitation filter and a 520-nm emission filter.

ER membrane staining {#Sec8}
--------------------

The cells for ER membrane staining were cultivated in tube at 30 °C and collected when OD~600~ reached 1. Then 1 OD~600~ of the cells were washed by 1× PBS twice and Hanks' Balance Salt Solution without phenol red (HBSS) once. The cell pellets were resuspended in 1 mL of HBSS with 5 μL of ER-Tracker Blue-White DPX (Thermo Fisher, Waltham, MA, USA), and incubated for 30 min at 30 °C. After the incubation, the cells were washed and resuspended in 1 mL of HBSS. 200 μL of the cell samples were loaded into 96-well black plate for detection by fluorescence microplate reader with a 355-nm excitation filter and a 590-nm emission filter.

Statistical method {#Sec9}
------------------

Student's t test was used for statistical significance testing in this study.

Results {#Sec10}
=======

Overexpression of *GCS1* or *GLO3* improves the titer of α-amylase in the *SEC16*-overexpression strain {#Sec11}
-------------------------------------------------------------------------------------------------------

To increase the protein secretory capacity in a *SEC16* overexpression strain by enlarging the retrograde trafficking pathway, two ARF GAPs mediating COPI vesicle formation, Gcs1p and Glo3p were overexpressed (Fig. [1](#Fig1){ref-type="fig"}a). Overexpression of *GCS1* or *GLO3* enhanced the titer of α-amylase 19.7 and 25.1%, respectively, when the cells were grown in tube cultures for 96 h (Fig. [1](#Fig1){ref-type="fig"}b). The final biomass yield of the *GCS1* or *GLO3* overexpression strains, YIGCS1 and YIGLO3, were slightly higher than the reference strain YIGS16 (Fig. [1](#Fig1){ref-type="fig"}b). Interestingly, we found that overexpression of *GCS1* or *GLO3* in the reference strain AACK (yeast strain without overexpression of *SEC16*) significantly decreased the titer of α-amylase secretion (Fig. [1](#Fig1){ref-type="fig"}c). We also tried to overexpress *GCS1* and *GLO3* simultaneously in YIGS16, yet the α-amylase titer did not further increase compared with that of single overexpression of *GLO3* in YIGS16 (resulting in strain YIGLO3) (Additional file [1](#MOESM1){ref-type="media"}: Figure S1). This may be due to a redundant function provided by *GCS1* and *GLO3,* each one ensuring sufficient vesicular transport from the Golgi apparatus to the ER (Poon et al. [@CR24]). Hence, only overexpression of either *GCS1* or *GLO3* was considered in subsequent experiments.Fig. 1Overexpression of *GCS1* or *GLO3* by promoter replacement in the *SEC16*-overexpression strain (YIGS16) has a positive effect on α-amylase secretion. **a** Constructions of the vesicle trafficking engineering strains. *SEC16* is involved in COPII vesicle formation; *GCS1* and *GLO3* are involved in COPI vesicle formation. **b** The titer and biomass of YIGS16, YIGCS1 and YIGLO3. **c** The titer and biomass of AACK, AACK-GCS1 and AACK-GLO3. \*P \< 0.05; \*\*P \< 0.01; \*\*\*P \< 0.001. Measurements are reported as the average value ± standard deviation from independent triplicates

Overexpression of *GCS1* or *GLO3* does not increase ROS {#Sec12}
--------------------------------------------------------

Recombinant protein production may cause ROS accumulation in cells due to the requirement for additional capacity requirement for oxidative protein folding in the ER (Tu and Weissman [@CR34]; Tyo et al. [@CR35]). In this study, we aimed to return more necessary components for the anterograde trafficking process in YIGS16 to strengthen the recombinant protein transportation by amplifying the retrograde trafficking, and we therefore evaluated how the ROS level was altered in the strains with a more balanced vesicle trafficking. From this analysis we found that even though the *GCS1* and *GLO3* overexpression strains had increased α-amylase secretion this was not associated with additional ROS accumulation (Additional file [1](#MOESM1){ref-type="media"}: Figure S2). This implied that overexpression of *GCS1* or *GLO3* did not cause increased cellular stress.

Engineering the retrograde trafficking increases the surface of the ER membrane {#Sec13}
-------------------------------------------------------------------------------

As one of the functions of the retrograde transportation is retrieving the necessary proteins with the lipids for the continuous anterograde trafficking (Poon et al. [@CR24]), we were interested to test if there was any change in ER membrane surface in the engineered strains. We have shown previously that moderate expression of *SEC16* reduced ER membrane surface (AACK) so we therefore measured the ER membrane surfaces in YIGS16, YIGCS1 and YIGLO3 by ER labeling with the ER-Tracker Blue-white DPX (Echevarria et al. [@CR7]), and found that the surfaces of ER membranes in YIGCS1 and YIGLO3 were slightly higher than in YIGS16 (Fig. [2](#Fig2){ref-type="fig"}a). Meanwhile, we also stained the ER membranes of AACK, AACK-GCS1 and AACK-GLO3, and *GCS1* and *GLO3* overexpression in AACK also resulted in an increase in ER surface area (Fig. [2](#Fig2){ref-type="fig"}b). This suggested that the ER membrane was enlarged when *GCS1* or *GLO3* were overexpressed. Enlarged ER membrane was likely a result of more lipids returned to the ER by enhanced retrograde trafficking.Fig. 2The amounts of ER membrane of strains **a** YIGS16, YIGCS1 and YIGLO3. **b** AACK, AACK-GCS1 and AACK-GLO3 using ER-Tracker Blue-White DPX. The ER membrane changes were quantified by their fluorescence intensity. \*P \< 0.05; \*\*\*P \< 0.001. Measurements are reported as the average value ± standard deviation from independent triplicates

Strain YIGLO3 has higher α-amylase yield throughout the cultivation {#Sec14}
-------------------------------------------------------------------

As both strains YIGCS1 and YIGLO3 showed increased final α-amylase titer in tube fermentations (Fig. [1](#Fig1){ref-type="fig"}b), we investigated α-amylase secretion throughout a fermentation process. Strains were therefore cultured in batch bioreactors, and samples were taken for analysis throughout the fermentation (Fig. [3](#Fig3){ref-type="fig"}a, b). The secreted α-amylase yield (titer/biomass ratio) was calculated at five stages of the process, which included the exponential growth phase (OD~600nm~ ≈ 1), the end of the glucose growth phase, the middle of the ethanol growth phase, the end of the ethanol growth phase and at the end of the fermentation. The α-amylase yield was higher for YIGLO3 in all stages compared with the reference strain YIGS16, while YIGCS1 only showed a higher α-amylase yield in the end (Fig. [3](#Fig3){ref-type="fig"}c). There was no significant difference in the percentage of intracellular α-amylase and intracellular α-amylase per cell for the three strains (Fig. [3](#Fig3){ref-type="fig"}d and Additional file [1](#MOESM1){ref-type="media"}: Figure S3).Fig. 3Batch fermentation of the strain YIGS16, YIGCS1 and YIGLO3. The time course of **a** the biomass and **b** the α-amylase titer. **c** The titer/biomass ratio and **d** the percentage of intracellular α-amylase of the three strains at five different time points. Measurements are reported as the average value ± standard deviation from independent triplicates

Besides increased α-amylase secretion, physiological changes were also found for the engineered strains, especially for YIGLO3. Both YIGCS1 and YIGLO3 had higher maximum specific growth rates and higher final biomass titers compared with strain YIGS16 (Table [2](#Tab2){ref-type="table"}, Fig. [3](#Fig3){ref-type="fig"}a). YIGLO3 had a significantly higher specific α-amylase production rate and yield of α-amylase in the glucose phase (Table [2](#Tab2){ref-type="table"}). Additionally, YIGLO3 had a higher specific ethanol production rate, higher ethanol production peak, lower specific glycerol production rate and lower glycerol production peak compared with YIGS16 (Table [2](#Tab2){ref-type="table"}, Additional file [1](#MOESM1){ref-type="media"}: Figures S4b, c). In contrast, no significant difference was found in these parameters between YIGCS1 and YIGS16. Furthermore, the glucose consumption profile was similar for all three strains (Additional file [1](#MOESM1){ref-type="media"}: Figure S4a), and there were no significant changes in the specific glucose uptake rates among the three strains (Table [2](#Tab2){ref-type="table"}).Table 2Physiological parameters of YIGS16, YIGCS1 and YIGLO3Strainμ~max~r~S~r~p~*Y* ~*Sα*~r~E~r~G~YIGS160.194 ± 0.0031.21 ± 0.01158.12 ± 7.80130.47 ± 4.980.147 ± 0.0020.253 ± 0.005YIGCS10.226 ± 0.004\*\*\*1.16 ± 0.01\*\*154.36 ± 1.74128.93 ± 2.480.147 ± 0.0050.261 ± 0.007YIGLO30.217 ± 0.002\*\*1.25 ± 0.03182.90 ± 7.31\*145.92 ± 5.76\*0.165 ± 0.001\*\*\*0.231 ± 0.006\**μ*~*max*~ maximum specific growth rate (h^−1^) on glucose, *r*~*S*~ specific glucose uptake rate (g/(g-DCW)/h), *r*~*P*~ specific α-amylase production rate (U/(g-DCW)/h) on glucose, *Y*~*sα*~ yield of α-amylase from glucose (U/g), *r*~*E*~ specific ethanol production rate (g/(g-DCW)/h), *r*~*G*~ specific glycerol production rate (g/(g-DCW)/h)"\*" represents the statistical significance of the difference between the parameters of YIGCS1 or YIGLO3 and those of YIGS16. \*P \< 0.05; \*\*P \< 0.01; \*\*\*P \< 0.001. Measurements are reported as the average value ± standard deviation from independent triplicates

Overexpression of *GLO3* improves secretion of two other recombinant proteins {#Sec15}
-----------------------------------------------------------------------------

To investigate whether overexpression of *GLO3* can also increase the production of other recombinant proteins, two heterologous proteins, *Trichoderma reesei* endoglucanase I and *Rhizopus oryzae* glucan-1,4-α-glucosidase were evaluated. The production of both proteins significantly increased, about 30%, in the *GLO3* overexpression strain, and just as for YIGLO3 the final biomass titer of both strains increased about 5% compared to that of the corresponding reference strain (Fig. [4](#Fig4){ref-type="fig"}).Fig. 4Secretion of two recombinant proteins, endoglucanase and glucan 1,4-α-glucosidase, in the reference strain and *GLO3*-overexpression strain. \*\*\*P \< 0.001 Measurements are reported as the average value ± standard deviation from independent quadruplicates

Discussion {#Sec16}
==========

ER-to-Golgi translocation of recombinant proteins is mediated by COPII-coated vesicles (Jensen and Schekman [@CR16]). Previously, we showed that moderate overexpression (but not high-level overexpression) of *SEC16* in yeast improved protein secretion by enhancing the anterograde transport from the ER to the Golgi apparatus (Bao et al. [@CR2]). Meanwhile, the enhanced ER-to-Golgi flux caused by expressing *SEC16* resulted in more ER membranes and ER membrane proteins to be directed to the anterograde vesicles to the Golgi, and this resulted in reduced ER membranes (Bao et al. [@CR2]). COPI-coated vesicles are responsible for retrieving these essential components from the Golgi apparatus to the ER for continuous anterograde trafficking (Poon et al. [@CR24]). Here by overexpression of *GCS1* or *GLO3* we increased the retrograde trafficking from the Golgi to the ER in the YIGS16 background strain expressing *SEC16* and we also detected increased amounts of ER membranes in YIGCS1 and YIGLO3. Hereby more essential components were recycled to the ER and could be reused for anterograde trafficking, resulting in increased protein secretion.

In the mammalian cells, interference of COPI vesicle formation by the addition of ArfGEF inhibitor brefeldin A shows a negative effect on ER export (Ward et al. [@CR38]), which may result from the shortage of the protein components required for the COPII vesicle assembly that occurs since the retrograde trafficking from the Golgi to the ER was inadequate (Brandizzi and Barlowe [@CR3]). A similar phenomenon was observed that the secretory pathway was impaired when the anterograde trafficking was disturbed by the disruption of COPII vesicle formation using Sar1p \[H79G\], a GTP locked version (Aridor et al. [@CR1]; Pepperkok et al. [@CR22]; Ward et al. [@CR38]). These results imply that the balance between anterograde and retrograde trafficking plays an important role in the secretory pathway. Wildtype *S. cerevisiae* has a limited protein secretory capacity and secretes naturally only a few proteins such as α-factor, invertase, and aspartyl protease (Carlson et al. [@CR4]; Idiris et al. [@CR15]; Komano et al. [@CR17]). In our previous study, we found that increasing the anterograde trafficking by moderate expression of *SEC16* improves the yeast secretory pathway (Bao et al. [@CR2]), which implies the natural anterograde trafficking flow in *S. cerevisiae* is inadequate. When only *GLO3* or *GCS1* was overexpressed in the wildtype strain AACK, the titer of α-amylase was decreased. This may be due to the inadequacy of the anterograde trafficking as the retrograde trafficking was overflown. However, when *GLO3* or *GCS1* were overexpressed in the anterograde trafficking amplifying strain YIGS16, the secretory capacity could be further increased. This might be the trafficking flow between the ER and the Golgi apparatus was improved by engineering the retrograde trafficking, reaching a better balance. In the controlled condition, the effect of *GCS1* overexpression on protein secretion was inconspicuous compared with *GLO3*. This is due to that Glo3p plays a major role in the COPI vesicle formation (Poon et al. [@CR24]), which could also explain AACK-GLO3 has an even lower α-amylase titer than AACK-GCS1 (Fig. [1](#Fig1){ref-type="fig"}c).

ER expansion by the deletion of the lipid-regulator *OPI1* alleviates ER stress and increases the secretion of IgG in *S. cerevisiae* (de Ruijter et al. [@CR6]; Schuck et al. [@CR28]). Interestingly, the overexpression of *GCS1* or *GLO3* increases the amounts of ER membranes in AACK and YIGS16, but has different effects on the secretion, which might be due to the two different manners of ER expansion. In our case, the ER was enlarged by amplifying the retrograde trafficking, while it was expanded through inducing the lipid biosynthesis genes by the deletion of *OPI1* (Schuck et al. [@CR28]).

In our previous study, we found that moderate overexpression of *SEC16* causes a lower specific growth rate and final biomass yield compared with the reference strain (Bao et al. [@CR2]). Here, the retrograde trafficking engineered strains, YIGCS1 and YIGLO3, showed higher specific growth rate and higher final biomass yield, which indicated that cellular stress caused by *SEC16* overexpression was reduced by anaplerosis of the retrograde trafficking. This could be the result that the trafficking flows were balanced between the ER and the Golgi apparatus through engineering the retrograde trafficking in the anterograde trafficking amplifying strain. Accordingly, there was no indication of increased oxidative stress in strains YIGCS1 and YIGLO3, as measured by ROS, despite a higher flux through the secretory pathway. In addition, we also observed that the titers were increased and the biomass was slightly, but significantly, in the strains with a balanced trafficking compared with the only anterograde trafficking amplifying strain, when overexpressing two other recombinant proteins. This implied that this vesicle trafficking balanced system could be used a general strategy for designing improved recombinant protein producing strains.

In conclusion, our strategy may be generally applicable for improving recombinant protein production in yeast, as we have shown that the strategy resulted in improved secretion of three different recombinant proteins when *GLO3* was overexpressed. In conclusion, we report the positive effect of engineering the retrograde trafficking in a *SEC16* moderate overexpression yeast strain on the secretion of three different recombinant proteins. We detected increased ER membrane surface and an unchanged ROS accumulation in the engineered strains, which suggest that increased trafficking turnover benefits recombinant protein secretion as well as the cellular stress level.
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ER

:   endoplasmic reticulum

UPR

:   unfolded protein response

ERES

:   endoplasmic reticulum exit site

COPII

:   coat protein complex II

COPI

:   coat protein complex I

ArfGEF

:   Arf1p guanine exchange factor

GAP

:   GTP activating protein

ROS

:   reactive oxygen species
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